When investigators shortlist peptides for a research protocol in the UAE, tesamorelin sits near the top of the GHRH analog category for one reason: the published evidence behind it is unusually solid. Falutz and colleagues' 2007 NEJM trial (412 subjects) documented a 15-18% reduction in visceral adipose tissue (VAT) and approximately 50% rise in IGF-1 versus placebo. Stanley's group at Massachusetts General then extended the research into HIV-associated non-alcoholic fatty liver disease, showing a 32% reduction in liver fat at 12 months (Stanley 2014, JAMA; Stanley 2019, Lancet HIV). That level of clinical investigation is rare for a research peptide — and it raises the standard for what a UAE supplier must actually deliver.
The problem is that the phrase "tesamorelin" on a label tells you very little about what is in the vial. Purity, identity, storage history, reconstitution excipients, and cold-chain integrity all determine whether the compound that arrives at a Dubai research site matches what Falutz and Stanley actually used. REVIVE LAB UAE was built specifically to close that gap: HPLC-verified tesamorelin, lot-COA supplied on request, and a refrigerated courier chain that covers every emirate — because a peptide that degrades in transit is not research-grade, it is a waste.
The term "research-grade" has a specific technical meaning that gets diluted by suppliers using it as a marketing badge. For tesamorelin — a synthetic 44-amino-acid GHRH analog with a trans-3-hexenoyl N-terminal modification — research grade requires all of the following, not just most:
REVIVE LAB UAE supplies tesamorelin that meets every criterion on this list. Every batch is HPLC-tested to ≥99% purity; the COA referencing the specific lot is available on request at the time of order. Vials are warehouse-held at 2-8°C in Dubai and dispatched in validated cold-chain insulation — not ice packs thrown in a polystyrene box, but engineered insulation that holds the 2-8°C window through the courier transit time in UAE summer conditions.
Tesamorelin is a GHRH analog — it binds the pituitary GHRH receptor and stimulates endogenous pulsatile growth hormone secretion. The trans-3-hexenoyl modification on the N-terminus confers resistance to dipeptidyl peptidase-IV (DPP-IV) cleavage, extending its half-life from the negligible ~7 minutes of native GHRH(1-44) to approximately 26 minutes after subcutaneous administration. This improved pharmacokinetics is precisely why investigators use the analog rather than the native peptide — but it also means the modification itself must be intact for the molecule to function. Heat, humidity, and oxidative stress selectively attack the N-terminus and the peptide backbone; a degraded vial may still test positive for peptide mass by low-resolution MS while delivering no meaningful GHRH-receptor agonism.
The pivotal research illustrates what an intact supply chain enables. In the Falutz 2007 NEJM trial — 412 HIV-positive subjects with abdominal fat accumulation randomised to tesamorelin 2mg/day or placebo — investigators using rigorously stored and refrigerated-transported investigational product observed a 15-18% reduction in VAT by CT scan at 26 weeks, alongside a ~50% increase in IGF-1. The 2010 26-week extension (Falutz et al., NEJM) confirmed durability of effect. The mechanism is downstream of GH: tesamorelin raises pulsatile GH, which elevates IGF-1, which in turn drives lipolysis preferentially in the visceral compartment.
Stanley and colleagues at MGH then pivoted this mechanism to HIV-associated NAFLD. In the 2014 JAMA trial, tesamorelin 2mg/day reduced liver fat — quantified by MR spectroscopy — by 32% relative to placebo. The 12-month randomised extension published in Lancet HIV (2019) confirmed that the liver fat reduction was sustained and that hepatic biomarkers improved in parallel. In every one of these programmes, the investigational product met pharmaceutical-grade storage standards. The results exist because the molecule was properly handled. A UAE researcher replicating this protocol using sub-standard supply loses the right to compare outcomes to the published literature.
| Vulnerability | Mechanism | Mitigation |
|---|---|---|
| N-terminal oxidation | Trans-3-hexenoyl group reacts with atmospheric oxygen | Nitrogen-purged vial headspace; airtight seal |
| Thermal denaturation (reconstituted) | Peptide loses helical conformation above ~15°C over time | Strict 2-8°C post-reconstitution; use within 14 days |
| DPP-IV re-cleavage | In-solution exposure to trace serine proteases | BAC water diluent inhibits microbial protease activity |
| Freeze-thaw damage | Ice crystal formation disrupts lyophilised matrix | Never freeze reconstituted vials; avoid <0°C storage |
| UV/light exposure | Aromatic side chains (Tyr, Phe, Trp) photodegradation | Amber glass vials; light-protected transit packaging |
REVIVE LAB UAE operates a warehouse in Dubai with climate-controlled peptide storage at 2-8°C year-round. When a researcher places an order, the pick-and-pack process happens in a refrigerated zone — vials are never exposed to ambient UAE temperature before being sealed into validated insulated packaging. The outer carton is plain and unbranded; the inner packaging is engineered to hold 2-8°C for the courier transit time, whether that is a 4-hour same-day run within Dubai or an 18-24 hour inter-emirate delivery.
This is what separates a credible peptides UAE supply chain from a generic drop-ship operation. Tesamorelin dispatched warm from a room-temperature warehouse in Dubai summer is a different product from tesamorelin maintained at 2-8°C from manufacture to door. The molecule does not forgive shortcuts.
REVIVE LAB UAE stocks tesamorelin in two vial sizes: 5mg and 10mg. These are the only strengths available — no 1mg or 2mg mini-vials. Reconstitution math is straightforward, and the 5mg or 10mg vials map cleanly onto the dosing schedule used in the Falutz and Stanley programmes (1mg or 2mg per day in a research context).
| Vial Size | BAC Water Added | Concentration | Volume per 1mg Research Dose | Volume per 2mg Research Dose |
|---|---|---|---|---|
| Tesamorelin 5mg | 1 mL | 5 mg/mL | 0.20 mL (20 IU) | 0.40 mL (40 IU) |
| Tesamorelin 5mg | 2 mL | 2.5 mg/mL | 0.40 mL (40 IU) | 0.80 mL (80 IU) |
| Tesamorelin 10mg | 2 mL | 5 mg/mL | 0.20 mL (20 IU) | 0.40 mL (40 IU) |
| Tesamorelin 10mg | 4 mL | 2.5 mg/mL | 0.40 mL (40 IU) | 0.80 mL (80 IU) |
Research-context dosing in the Falutz trials was 2mg/day administered as a single subcutaneous injection. The Stanley NAFLD programmes used the same 2mg/day schedule. Investigators replicating these protocols typically procure either 5mg vials for shorter research windows or 10mg vials for extended programmes, given that the 10mg vial allows 5 research-context daily doses at 2mg without the need for frequent reconstitution.
After reconstitution, vials must be stored at 2-8°C and used within 14 days. Never freeze a reconstituted vial — ice crystal formation irreversibly damages the peptide. Reconstitute slowly by injecting BAC water down the side of the vial and allowing the lyophilised cake to dissolve without agitation; do not shake or vortex.
REVIVE LAB UAE supplies HPLC-verified, lot-COA, cold-chain dispatched tesamorelin across all 7 emirates. Whether you are based in Dubai Marina, Business Bay, DIFC, JBR, Jumeirah, JVC, Palm Jumeirah, Downtown, Saadiyat Island, or Al Ain, the logistics chain is the same: refrigerated pick-and-pack, validated insulated packaging, tracked courier. To buy tesamorelin UAE from REVIVE LAB UAE, orders are placed directly via the product page; payment accepts cash on delivery (COD) across all emirates and USDT (TRC20) crypto payment via Binance Pay for researchers who prefer to settle digitally — a 5% pre-pay discount applies on the crypto option.
| Emirate / Key Areas | Delivery Window | Cash on Delivery | Cold-Chain Packaging |
|---|---|---|---|
| Dubai (Marina, JBR, Business Bay, DIFC, JVC, Palm, Downtown, Jumeirah, Emirates Hills) | Same-day, 4-8 hours | Yes | Yes |
| Sharjah | Same-day / next-day, 8-18 hours | Yes | Yes |
| Abu Dhabi (Corniche, Yas, Saadiyat, Reem, Al Raha) | Next-day, 18-24 hours | Yes | Yes |
| Ajman | Next-day, 18-24 hours | Yes | Yes |
| Ras Al Khaimah (RAK) | Next-day, 18-24 hours | Yes | Yes |
| Fujairah | Next-day, up to 24 hours | Yes | Yes |
| Umm Al Quwain (UAQ) | Next-day, 18-24 hours | Yes | Yes |
| Al Ain | Next-day, up to 24 hours | Yes | Yes |
A researcher in Dubai ordering before the daily cut-off typically receives cold-chain vials the same afternoon. For inter-emirate orders, the refrigerated courier network reaches Abu Dhabi, Sharjah, RAK, Fujairah, UAQ, Ajman and Al Ain within the next-day window. Tesamorelin Dubai 24h delivery is the default, not an upsell — and tesamorelin same day Dubai is available for in-city orders that come in before cut-off.
It is worth being direct about why supply-chain quality matters for tesamorelin specifically, rather than treating it as generic procurement guidance. The Falutz 2007 NEJM trial — the foundation of all tesamorelin research — enrolled 412 subjects with HIV-associated lipodystrophy and used pharmaceutical-grade investigational product that had never been exposed to warm storage or non-sterile reconstitution. The 15-18% VAT reduction and ~50% IGF-1 increase reported in that trial are the benchmark figures that every downstream investigator references. When a researcher in the UAE uses degraded or contaminated tesamorelin, they are not running a reduced version of Falutz 2007; they are running a different experiment with an unknown compound.
The same logic applies to the Stanley NAFLD work. The 2014 JAMA paper and the 2019 Lancet HIV extension both used pharmaceutical-grade tesamorelin with rigorous cold-chain protocols at Massachusetts General Hospital. The 32% liver fat reduction and the 12-month durability data are what they are because the molecule arrived at the injection site intact. Researchers replicating this protocol — or citing these studies as context for their own work — need supply that meets the same standard.
REVIVE LAB UAE's position is simple: HPLC verification and cold-chain dispatch are not optional extras for a price-premium tier. They are the minimum that makes the supply worth calling research-grade. Every tesamorelin vial dispatched from Dubai goes out verified and cold.
Yes. REVIVE LAB UAE stocks tesamorelin 5mg and 10mg vials in Dubai. Researchers in Dubai typically receive same-day delivery in 4-8 hours for orders placed before the daily cut-off. All other emirates are covered within 18-24 hours. Both cash on delivery and USDT TRC20 crypto payment via Binance Pay are accepted — the crypto option carries a 5% pre-pay discount. Search terms like tesamorelin in stock UAE or tesamorelin Dubai 24h delivery lead here for a reason: the stock is local, not drop-shipped.
Research-grade requires HPLC-confirmed identity and ≥99% purity, plus a lot-specific COA traceable to the batch number on the vial. REVIVE LAB UAE provides this documentation on request with every order. A generic purity claim without a lot number and instrument data is marketing, not a COA. Ask for the COA before placing any order with any peptides UAE supplier — if they cannot provide it, the batch is unverified.
REVIVE LAB UAE stocks tesamorelin 5mg and 10mg vials only. Research-context dosing referenced in the Falutz and Stanley programmes used 1mg or 2mg per day; the 5mg or 10mg vials accommodate these schedules over 2.5 to 10 days per vial depending on dose and concentration chosen at reconstitution. No other strengths are stocked. If a UAE supplier lists tesamorelin in 1mg or 2mg vials, verify the source carefully — these are non-standard formats not typically seen in validated research supply chains.